Evidence map›Paper›PMID 25569618›Full record

ArticleAmerican journal of respiratory cell and molecular biology2015

Resistin-Like Molecule α in Allergen-Induced Pulmonary Vascular Remodeling.

Chunling Fan, Lucas W Meuchel, Qingning Su, Daniel J Angelini, Ailan Zhang, Chris Cheadle, Irina Kolosova, Oleg D Makarevich, Kazuyo Yamaji-Kegan, Marc E Rothenberg and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Airway Goblet Metaplasia Resulting from YAP/TAZ Deletion Drives Pulmonary Inflammatory Responses.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Regulatory Peptides in Asthma.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Review
  13. Resistin family proteins in pulmonary diseases.American journal of physiology. Lung cellular and molecular physiology · 2020
    Review
  14. Inhalation ofAmerican journal of respiratory cell and molecular biology · 2020
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Chunling Fan1 Department of Anesthesiology and Critical Care Medicine and.
Lucas W Meuchel1 Department of Anesthesiology and Critical Care Medicine and.
Qingning Su2 School of Medicine, Shenzhen University, Shenzhen, China.
Daniel J Angelini1 Department of Anesthesiology and Critical Care Medicine and.
Ailan Zhang1 Department of Anesthesiology and Critical Care Medicine and.
Chris Cheadle3 Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Irina Kolosova1 Department of Anesthesiology and Critical Care Medicine and.
Oleg D Makarevich4 University of Maryland, Baltimore, Maryland; and.
Kazuyo Yamaji-Kegan1 Department of Anesthesiology and Critical Care Medicine and.
Marc E Rothenberg5 Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Roger A Johns1 Department of Anesthesiology and Critical Care Medicine and.
Society of Critical Care Medicine · USCincinnati Children's Hospital Medical Center · USJohns Hopkins University · USShenzhen University · CNUniversity of Maryland, Baltimore · US

Funding

SCLERODERMA-ASSOCIATED PAHP50HL084946 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLUEMKE, DAVID A. · 2007 to 2011
$20.6M
Targeting resitin and RELM-beta to treat pulmonary hypertensionUH3HL123827 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2016 to 2018
$4.9M
Targeting resitin and RELM-beta to treat pulmonary hypertensionUH2HL123827 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2014 to 2015
$3.1M
Targeting resitin and RELM-beta to treat pulmonary hypertensionP50HL107182 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2011 to 2012
$983k
NHLBI NIH HHS P50 HL084946NHLBI NIH HHS P50 HL107182NHLBI NIH HHS P50HL 107182NHLBI NIH HHS UH2 HL123827NHLBI NIH HHS UH3 HL123827PHS HHS P50 084946
6 · The paper itself

Abstract

Resistin-like molecule α (RELMα) has mitogenic, angiogenic, vasoconstrictive, and chemokine-like properties and is highly relevant in lung pathology. Here, we used RELMα knockout (Retnla(-/-)) mice to investigate the role of RELMα in pulmonary vascular remodeling after intermittent ovalbumin (OVA) challenge. We compared saline- and OVA-exposed wild-type (WT) mice and found that OVA induced significant increases in right ventricular systolic pressure, cardiac hypertrophy, pulmonary vascular remodeling of intra-alveolar arteries, goblet cell hyperplasia in airway epithelium, and intensive lung inflammation, especially perivascular inflammation. Genetic ablation of Retnla prevented the OVA-induced increase in pulmonary pressure and cardiac hypertrophy seen in WT mice. Histological analysis showed that Retnla(-/-) mice exhibited less vessel muscularization, less perivascular inflammation, reduced medial thickness of intra-alveolar vessels, and fewer goblet cells in upper airway epithelium (250-600 μm) than did WT animals after OVA challenge. Gene expression profiles showed that genes associated with vascular remodeling, including those related to muscle protein, contractile fibers, and actin cytoskeleton, were expressed at a lower level in OVA-challenged Retnla(-/-) mice than in similarly treated WT mice. In addition, bronchoalveolar lavage from OVA-challenged Retnla(-/-) mice had lower levels of cytokines, such as IL-1β, -1 receptor antagonist, and -16, chemokine (C-X-C motif) ligand 1, -2, -9, -10, and -13, monocyte chemoattractant protein-1, macrophage colony-stimulating factor, TIMP metallopeptidase inhibitor-1, and triggering receptor expressed on myeloid cells-1, than did that from WT mice when analyzed by cytokine array dot blots. Retnla knockout inhibited the OVA-induced T helper 17 response but not the T helper 2 response. Altogether, our results suggest that RELMα is involved in immune response-induced pulmonary vascular remodeling and the associated increase in inflammation typically observed after OVA challenge.

Indexed as

AllergensAnimalsCytokinesHypertension, PulmonaryIntercellular Signaling Peptides and ProteinsLungMaleMice, Inbred BALB CMice, KnockoutOvalbuminVascular RemodelingAllergensCytokinesIntercellular Signaling Peptides and ProteinsOvalbuminRetnla protein, mouseinflammationpulmonary hypertensionresistin-like molecule αT helper 17vascular remodeling

Identifiers

PMID25569618
PMCPMC4566066
OpenAlexW2072663928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.